Iron overload Information & Iron overload Links at HealthHaven.com
advertise
add site
services
publishers
database
health videos
Bookmark and Share

search wiki for    ?
web dir firms image gallery news pdf wiki shop video 
about
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
Featured Results:
 Haemochromatosis - Symptom, Treatment and cause of Haemochromatosis
Haemochromatosis - Symptom, Treatment and cause of Haemochromatosis
disease-condition.com
  Haemochromatosis . DermNet NZ
Haemochromatosis. DermNet NZ
dermnetnz.org
  Haemochromatosis
Haemochromatosis
medic8.com
 Investigating and Managing Haemochromatosis ...
Investigating and Managing Haemochromatosis...
gesa.org.au
 
Iron overload
Hemosiderosis high mag.jpg

Micrograph of hemosiderosis. Liver biopsy. Iron stain.
ICD-10 R79.0
ICD-9 790.6
DiseasesDB 5581
MeSH D019190

In medicine, iron overload (also known as haemochromatosis) indicates accumulation of iron in the body due to any cause.

Contents

[edit] Terminology

Historically, the term "haemochromatosis" was initially used to refer to what is now more specifically called haemochromatosis type 1 (or HFE-related hereditary haemochromatosis). The term is currently used more broadly to refer to any form of iron overload, thus requiring specification of the cause. The term haemosiderosis is used to indicate the pathological effect of iron accumulation in any given organ, which mainly occurs in the form of haemosiderin; sometimes the simpler term siderosis is used in its stead. The terms haemosiderosis and siderosis tend to be used when iron accumulation occurs only in a specific organ (such as the lung) as opposed to the whole body in haemochromatosis.

[edit] Clinical presentation

Organs commonly affected by haemochromatosis are the liver, heart and endocrine glands.[1]

[edit] Causes

The causes can be distinguished between primary cases (genetically determined) and less frequent secondary cases (acquired during life).[2]

[edit] Primary haemochromatosis

The fact that most cases of haemochromatosis were inherited was well known for most of the 20th century, though they were incorrectly assumed to depend on a single gene.[3] The overwhelming majority actually depend on mutations of the HFE gene discovered in 1996, but since then others have been discovered and sometimes are grouped together as "non-classical hereditary haemochromatosis"[4], "non-HFE related hereditary haemochromatosis".[5], or "non-HFE haemochromatosis".[6]

Description OMIM Mutation
haemochromatosis type 1: "classical"-haemochromatosis 235200 HFE
Haemochromatosis type 2A: juvenile haemochromatosis 602390 haemojuvelin ("HJV", also known as RGMc and HFE2)
Haemochromatosis type 2B: juvenile haemochromatosis 606464 hepcidin antimicrobial peptide (HAMP) or HFE2B
Haemochromatosis type 3 604250 transferrin receptor-2 (TFR2 or HFE3)
Haemochromatosis type 4/
African iron overload
604653 ferroportin (SLC11A3/SLC40A1)
Neonatal haemochromatosis 231100 (unknown)
Acaeruloplasminemia (very rare) 604290 caeruloplasmin
Congenital atransferrinaemia (very rare) 209300 transferrin
GRACILE syndrome (very rare) 603358 BCS1L

Most types of hereditary haemochromatosis have autosomal recessive inheritance, while type 4 has autosomal dominant inheritance.[7]

[edit] Secondary haemochromatosis

[edit] Treatment

Routine treatment in an otherwise healthy person consists of regularly scheduled phlebotomies (bloodletting). When first diagnosed, the phlebotomies may be fairly frequent, perhaps as often as once a week, until iron levels can be brought to within normal range. Once iron (Fe) and other markers are within the normal range, phlebotomies may be scheduled every other month or every three months depending upon the patient's rate of iron loading.

For those unable to tolerate routine blood draws, there is a chelating agent available for use. The drug Deferoxamine binds with iron in the blood stream and enhances its elimination via urine and feces. Typical treatment for chronic iron overload requires subcutaneous injection (SQ) over a period of 8-12 hours daily.

[edit] See also

[edit] References

  1. ^ Andrews NC (1999). "Disorders of iron metabolism". N. Engl. J. Med. 341 (26): 1986–95. doi:10.1056/NEJM199912233412607. PMID 10607817. 
  2. ^ Pietrangelo A (May 2003). "Haemochromatosis". Gut 52 Suppl 2: ii23–30. PMID 12651879. PMC 1867747. http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=12651879. 
  3. ^ Cam Patterson; Marschall S. Runge (2006). Principles of molecular medicine. Totowa, NJ: Humana Press. pp. 567. ISBN 1-58829-202-9. 
  4. ^ Mendes AI, Ferro A, Martins R, et al. (March 2009). "Non-classical hereditary haemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes". Ann. haematol. 88 (3): 229–34. doi:10.1007/s00277-008-0572-y. PMID 18762941. http://dx.doi.org/10.1007/s00277-008-0572-y. 
  5. ^ Maddrey, Willis C.; Schiff, Eugene R.; Sorrell, Michael F. (2007). Schiff's diseases of the liver. Hagerstwon, MD: Lippincott Williams & Wilkins. pp. 1048. ISBN 0-7817-6040-2. 
  6. ^ Pietrangelo A (November 2005). "Non-HFE haemochromatosis". Semin. Liver Dis. 25 (4): 450–60. doi:10.1055/s-2005-923316. PMID 16315138. 
  7. ^ Franchini M (March 2006). "Hereditary iron overload: update on pathophysiology, diagnosis, and treatment". Am. J. haematol. 81 (3): 202–9. doi:10.1002/ajh.20493. PMID 16493621. 

[edit] External links





Product Results (view all...)

search wiki for    ?
web dir firms image gallery news pdf wiki shop video 



↑ top of page ↑about thumbshots